Odds for Dementia Nearly Triple in the Year After a Stroke
Medically reviewed by Drugs.com.
By Ernie Mundell HealthDay Reporter
THURSDAY, Feb. 1, 2024 -- A person's odds for a dementia diagnosis nearly triple in the first year after a stroke, new research shows.
This post-stroke spike in dementia risk does subside with time, but it never returns to pre-stroke levels, the same report found.
"Our findings reinforce the importance of monitoring people with stroke for cognitive decline," said lead researcher Dr. Raed Joundi. He's an assistant professor at McMaster University in Hamilton, Ontario, Canada.
Joundi's team will present its findings next week at the annual International Stroke Conference in Phoenix, sponsored by the American Heart Association (AHA).
In the study, the Canadian team combed through a database with information on more than 15 million people living in Ontario.
They looked closely at data on almost 181,000 people who'd recently suffered a stroke, and compared their health outcomes to those of matched controls. Controls were either healthy people without a history of stroke or heart attack or folks who'd had a heart attack but not a stroke.
Joundi's group also tracked the incidence of dementia diagnosed within 90 days of a stroke, with follow-up continuing for 5.5 years.
They found that risks for a dementia diagnosis rose nearly three-fold during the first year after a stroke, then subsided to a 1.5-fold higher risk by the five-year mark. Risks were still slightly elevated even 20 years later, the team added.
Overall, 19% of stroke survivors developed dementia over the 5.5 years of follow-up, and survivors had a dementia risk that was 80% higher than that of the general population, or of that of people who'd survived a heart attack but hadn't experienced stroke.
The type of stroke seemed to matter: People who'd survived an intracerebral hemorrhage (bleeding in the brain, a rarer form of stroke), were 150% more likely than the general population to develop dementia, the study found.
In fact, “we found that the rate of post-stroke dementia was higher than the rate of recurrent stroke over the same time period,” Joundi said in an AHA news release.
“Stroke injures the brain, including areas critical for cognitive function, which can impact day-to-day functioning," he explained. "Some people go on to have a recurrent stroke, which increases the risk of dementia even further, and others may experience a progressive cognitive decline similar to a neurodegenerative condition.”
How can the risk for post-stroke dementia be reduced?
More effort needs to go toward "instituting appropriate treatments to address vascular risk factors and prevent recurrent stroke, and encouraging lifestyle changes, such as smoking cessation and increased physical activity, which have many benefits and may reduce the risk of dementia,” Joundi said.
Also, “more research is needed to clarify why some people who have a stroke develop dementia and others do not," he added.
Because this data was presented at a medical meeting, the findings should be considered preliminary until published in a peer-reviewed journal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-01 22:15
Read more
- USPSTF Recommends Providing Interventions to Support Breastfeeding
- Long-Term Complications After Prostate Cancer Treatment Not Uncommon
- Dose-Dependent Association Seen for Smoking, CVD Risk
- FDA Approves Hympavzi for Hemophilia
- Light Physical Activity Linked to Improved Vascular Parameters in RA
- ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in Women
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions